What Aurora Diagnostics does

Aurora Diagnostics, now operating as the Anatomic Pathology division of Sonic Healthcare USA, is a U.S. anatomic pathology services provider founded in 2006. The company delivers diagnostic pathology services through a national network of clinical laboratories and pathology practices, employing 380+ pathologists organized under a Medical Leadership model that emphasizes subspecialty expertise. Core service offerings include Anatomic Pathology (surgical pathology, cytopathology, clinical pathology consultations), Dermatopathology (skin disease diagnostics including melanoma and carcinoma evaluation), Molecular Diagnostics (genomic and genetic analyses), and Hospital Services. Featured testing solutions extend into higher-value specialty areas: ThyroSeq for thyroid cancer molecular testing, AuraSeq for genomic sequencing, Women's Health panels, Companion Diagnostics for therapeutic biomarker identification, and COVID-19 testing. Clinician workflow is supported through the ConnectDX digital platform, specimen submission infrastructure, and a searchable online Test Menu, while patient-facing resources include education materials (English and Spanish) and cost savings programs.

The company's go-to-market is sales-led, targeting hospitals, healthcare facilities, and clinicians through direct enterprise relationships, with a secondary patient-facing channel for billing, education, and financial assistance. Revenue is generated through professional services billing for diagnostic testing to healthcare providers and patients. The company pursues a vertical segmentation approach within healthcare, addressing diagnostic testing, pathology consultation, molecular diagnostics, and hospital pathology service needs. Following a period of aggressive inorganic growth (seven acquisitions completed between 2015 and 2017), the business was integrated into Sonic Healthcare Limited (ASX:SHL), an Australian publicly listed diagnostic conglomerate, as the U.S. Anatomic Pathology division headquartered in Dallas, TX.

Technology differentiation centers on subspecialty pathologist expertise, proprietary featured testing solutions (AuraSeq, ThyroSeq), and the Medical Leadership organizational model rather than platform technology. No AI/ML capabilities, APIs, or software product lines are disclosed; the digital footprint is limited to clinician workflow tooling (ConnectDX) and patient resource portals. The company serves millions of patients annually across the United States, with operations confined to the domestic market.

Name

Aurora Diagnostics

Legal name

Sonic Healthcare USA

Website

https://auroradx.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Aurora Diagnostics operates as Sonic Healthcare USA's Anatomic Pathology division, providing diagnostic pathology, dermatopathology, molecular diagnostics, and hospital services through 380+ pathologists across a national network of clinical laboratories serving hospitals, clinicians, and patients in the United States.

Ownership category

akta.pro rank

Product category

Diagnostic Pathology Services

NAICS

Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)

akta.pro secondary industries

Dermatopathology (HLAKACAC), Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces (HLACAMAJ), Independent Diagnostic Testing Facilities (IDTFs) & Multi-Specialty Diagnostic Centers (HLAFAKAN)

Keywords

• Anatomic pathology services
• Diagnostic laboratory testing
• Molecular diagnostics
• Dermatopathology services
• Hospital pathology services

Headquarters

HQ city

Palm Beach Gardens

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Pathology Services: Provides anatomical pathology, dermatopathology, molecular diagnostics, and hospital services to healthcare providers. Revenue generated through diagnostic testing services billed to healthcare facilities, hospitals, and patients.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Aurora Diagnostics (now Sonic Healthcare USA Anatomical Pathology) provides anatomic pathology, dermatopathology, molecular diagnostics, and hospital pathology services through a national network of clinical laboratories. The company offers specialized testing solutions including AuraSeq genomic sequencing, ThyroSeq thyroid cancer testing, Women's Health diagnostics, Companion Diagnostics, and COVID-19 testing. Its 380+ pathologists deliver diagnostic, prognostic, and therapeutic testing services to healthcare facilities, hospitals, and clinicians across the United States.

Product overview

Aurora Diagnostics operates as a division of Sonic Healthcare USA, providing a comprehensive anatomical pathology service platform with a network of 380+ pathologists serving millions of patients. The core offering centers on Anatomic Pathology services supplemented by specialized subspecialty areas including Dermatopathology and Molecular Diagnostics. The portfolio includes featured testing solutions such as AuraSeq (genomic sequencing), ThyroSeq (thyroid cancer testing), Women's Health panels, Companion Diagnostics, and COVID-19 testing. Supporting clinician workflow through ConnectDX digital platform and a comprehensive online Test Menu, the company delivers integrated diagnostic services to both healthcare providers and patients through hospital-based and outpatient settings across the United States.

Differentiator

Problem solved

Functional benefit

Products and services

• Anatomic Pathology Comprehensive diagnostic pathology services providing assessment of tissue samples for disease diagnosis, including surgical pathology, cytopathology, and clinical pathology consultations, for healthcare providers and clinicians.
• Dermatopathology Specialized pathology services focused on skin diseases, providing diagnostic evaluation of skin biopsies and specimens for conditions including melanoma, basal cell carcinoma, and squamous cell carcinoma, for clinicians and dermatology practices.
• Molecular Diagnostics Advanced molecular testing services including genetic and genomic analyses for disease detection, diagnosis, and treatment guidance for healthcare providers.
• Hospital Pathology Services Comprehensive pathology services designed for hospital settings, supporting integrated patient care with rapid and accurate diagnostic results for hospitals and inpatient care teams.
• AuraSeq Genomic Sequencing Advanced genomic sequencing testing solution for precision medicine applications, offered to clinicians through Sonic Healthcare USA Anatomic Pathology.
• ThyroSeq Thyroid Cancer Testing Specialized thyroid cancer molecular testing solution for improved diagnosis and treatment planning of thyroid nodules, available through Sonic Healthcare USA Anatomic Pathology.
• Women's Health Diagnostic Testing Comprehensive diagnostic testing panel focused on women's health conditions including reproductive health and gynecologic conditions, offered to clinicians and patients.
• Companion Diagnostics Diagnostic tests designed to identify biomarkers that predict patient response to specific therapeutic treatments, supporting personalized medicine for clinicians and oncologists.
• COVID-19 Diagnostic Testing Diagnostic testing services for detection of SARS-CoV-2 infection, supporting patient diagnosis, management, and public health response for healthcare providers and patients.

Quantifiable outcome

• Millions of patients served through network of pathology practices

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered featured and core.

• ThyroSeqfeaturedTechnology or IntegrationThyroSeq is featured as a testing solution on the Sonic Healthcare USA Anatomic Pathology platform, indicating a partnership or integration for thyroid cancer diagnostic testing services.
• Sonic Research NetworkcoreStrategic or Co-development PartnerSonic Research Network provides research capabilities for the pathology network, supporting clinical research initiatives and advancing diagnostic medicine through collaborative research efforts.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Quest Diagnostics: Largest U.S. clinical laboratory and diagnostics company offering anatomic pathology, molecular diagnostics, and hospital/reference lab services. Directly comparable in customer base (hospitals, clinicians) and core service lines to Aurora Diagnostics.
• Laboratory Corporation of America (Labcorp): Major U.S. diagnostics provider with extensive anatomic pathology, molecular, and specialty testing offerings. Closely comparable in scope, scale of pathologist network, and hospital/health system customer focus.
• NeoGenomics: Specialized oncology and anatomic pathology lab with strong presence in molecular and hematopathology. Comparable specialty-testing positioning, particularly in oncology diagnostics and hospital channel sales.
• BioReference Laboratories (OPKO Health): U.S. full-service clinical and anatomic pathology laboratory serving hospitals, clinicians, and patients. Directly comparable in service mix (anatomic pathology, molecular, women's health) and hospital channel focus.

Broad incumbents

• Sonic Healthcare Limited: Australian parent of Aurora Diagnostics; one of the world's largest diagnostics companies with global anatomic pathology operations. Comparable because it is the parent and operates the same pathology service model across multiple geographies.

Emerging players

• Guardant Health: Specialized molecular diagnostics company focused on oncology liquid biopsy and companion diagnostics. Comparable in molecular/companion diagnostics offerings (e.g., AuraSeq, Companion Diagnostics at Aurora) but narrower oncology focus.
• Foundation Medicine (Roche): Specialized molecular profiling and companion diagnostics company serving oncologists and biopharma. Comparable in advanced genomic sequencing and companion diagnostic capabilities overlapping with Aurora's molecular/precision medicine tests.
• Caris Life Sciences: Specialty molecular diagnostics and AI-driven pathology company offering comprehensive tumor profiling and companion diagnostics. Overlaps with Aurora's molecular diagnostics and companion diagnostics product lines.
• PathAI: AI-driven digital pathology company developing diagnostic and biomarker tools for anatomic pathology. Comparable as a technology-enabled pathology player, though primarily a technology partner rather than a full-service lab competitor.
• Exact Sciences: Diagnostics company with Cologuard and Oncotype DX products spanning molecular diagnostics and oncology. Comparable in molecular diagnostics and companion diagnostic offerings relevant to Aurora's precision medicine portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/aurora-diagnostics
• Xx.com/aurora_dx
• Facebookfacebook.com/AuroraDiagnostics

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A7 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aurora Diagnostics